MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques.
BACKGROUND: Continuous high global tuberculosis (TB) mortality rates and variable vaccine efficacy of Mycobacterium bovis Bacille Calmette-Guérin (BCG) motivate the search for better vaccine regimes. Relevant models are required to downselect the most promising vaccines entering clinical efficacy t...
Main Authors: | Verreck, F, Vervenne, R, Kondova, I, van Kralingen, K, Remarque, E, Braskamp, G, van der Werff, N, Kersbergen, A, Ottenhoff, T, Heidt, P, Gilbert, S, Gicquel, B, Hill, A, Martin, C, Mcshane, H, Thomas, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Correction: MVA.85A Boosting of BCG and an Attenuated, Deficient Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques.
by: Frank A. W. Verreck, et al.
Published: (2011-01-01) -
Correction: MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques
Published: (2011-01-01) -
Structural insights into transcription regulation of the global OmpR/PhoB family regulator PhoP from Mycobacterium tuberculosis
by: Jing Shi, et al.
Published: (2025-02-01) -
Mycobacterium tuberculosis PhoP integrates stress response to intracellular survival by regulating cAMP level
by: Hina Khan, et al.
Published: (2024-05-01) -
Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
by: Mcshane, H, et al.
Published: (2005)